ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years
Shailender Singh
Matched on OpenAlex author ID A5113683142. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis. Co-author DOI 10.1053/j.gastro.2023.12.018↗
- Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Co-author DOI 10.1016/j.bbcan.2019.188318↗
- A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. Co-author DOI 10.1038/ajg.2016.482↗
- Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. Co-author DOI 10.1371/journal.pone.0055171↗
- Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study. First author PMID 24714323↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 4 shared papers, 2013–2024 · strength 0.36
- Paper Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LA… DOI 10.1053/j.gastro.2023.12.018↗
- Paper Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). DOI 10.1016/j.bbcan.2019.188318↗
- Paper A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. DOI 10.1038/ajg.2016.482↗
- Sukhwinder Kaur · 3 shared papers, 2013–2020 · strength 0.19
- Paper Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). DOI 10.1016/j.bbcan.2019.188318↗
- Paper A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. DOI 10.1038/ajg.2016.482↗
- Paper Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. DOI 10.1371/journal.pone.0055171↗
- Maneesh Jain · 3 shared papers, 2013–2020 · strength 0.19
- Paper Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). DOI 10.1016/j.bbcan.2019.188318↗
- Paper A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. DOI 10.1038/ajg.2016.482↗
- Paper Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. DOI 10.1371/journal.pone.0055171↗
- Frank Leon · 1 shared paper, 2024 · strength 0.18
- Ayoola O. Ogunleye · 1 shared paper, 2024 · strength 0.18
- Palanisamy Nallasamy · 1 shared paper, 2024 · strength 0.18
- Sanchita Rauth · 1 shared paper, 2024 · strength 0.18
- Seema C. Parte · 1 shared paper, 2024 · strength 0.18
- Jesse L. Cox · 1 shared paper, 2024 · strength 0.18
- Subodh M. Lele · 1 shared paper, 2024 · strength 0.18
- Rama Krishna Nimmakayala · 1 shared paper, 2024 · strength 0.18
- Zahraa Wajih Alsafwani · 1 shared paper, 2024 · strength 0.18
- Moorthy Palanimuthu Ponnusamy · 1 shared paper, 2024 · strength 0.18
- Asish Patel · 2 shared papers, 2017–2020 · strength 0.15
- Uwe A. Wittel · 2 shared papers, 2013–2020 · strength 0.13
- Subhankar Chakraborty · 2 shared papers, 2013 · strength 0.11
- Pranita Atri · 1 shared paper, 2020 · strength 0.10
- Geoffrey A. Talmon · 1 shared paper, 2020 · strength 0.10
- Joseph Carmicheal · 1 shared paper, 2020 · strength 0.10
- Mokenge Peter Malafa · 1 shared paper, 2020 · strength 0.10
- Lynette M. Smith · 2 shared papers, 2013–2017 · strength 0.09
- Randall E. Brand · 2 shared papers, 2013–2017 · strength 0.09
- Sushovan Guha · 2 shared papers, 2013–2017 · strength 0.09
- Kavita B. Mallya · 2 shared papers, 2013–2017 · strength 0.09
- Chandrakanth Are · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.